Definitions of biochemical failure in prostate cancer following radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 5, 2001, Pages 1212-1219

  Taylor, Jeremy M G ^a   Griffith, Kent A ^a   Sandler, Howard M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Biochemical failure; Clinical endpoint; Prostate cancer; Prostate specific antigen; Receiver operating characteristic curves

Indexed keywords

ANTIGENS; HORMONES; ONCOLOGY; RADIATION; TUMORS;

BIOCHEMICAL FAILURE; PROSTATECTOMY;

RADIOTHERAPY;

BIOCHEMICAL MARKER; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; EVALUATION; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; COMBINED MODALITY THERAPY; ENDPOINT DETERMINATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; ROC CURVE; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035425401     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01571-1     Document Type: Article

References (12)

1. Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications
2. Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control
3. Consensus Statement: Guidelines for PSA following radiation therapy
4. Changes in biochemical disease-free survival. Rates as a result of adoption of the Consensus Conference definition in patients with clinically localized prostate cancer treated with external beam radiotherapy
5. Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness
6. The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation
7. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer
8. Caution in interpreting biochemical control rates after treatment for prostate cancer. Length of follow-up influences results
9. Surrogate endpoints in clinical trials: Definition and operational criteria
10. Perspective. Validating surrogate markers - Are we being Naïve?
11. PSA-free survival following radical prostatectomy, external beam radiation therapy or brachytherapy is associated with significant benefit in health-related quality of life
12. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study